Papers: 12 Jul 2013 - 19 Jul 2013
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
Visual pathway abnormalities were found in most multiple sclerosis patients despite history of previous optic neuritis.
Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors.
Theiler's murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption.
[Acute transverse myelitis after allogeneic bone marrow transplantation for acute lymphoblastic leukemia--a case report].
Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
The role of cytomegalovirus, haemophilus influenzae and epstein barr virus in guillain barre syndrome.
A comparative study of magnetic resonance venography techniques for the evaluation of the internal jugular veins in multiple sclerosis patients.
Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms.
Myocarditis and diffuse skeletal muscle oedema: new features of neuromyelitis optica spectrum disorder? A case report.
Using Observational Analysis of Multiple Sclerosis Relapse to Design Outcomes-Based Contracts for Disease-Modifying Drugs: A Feasibility Assessment.
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome.
Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.
Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease.
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
Rapidly progressive amyotrophic lateral sclerosis initially masquerading as a demyelinating neuropathy.